Unlock instant, AI-driven research and patent intelligence for your innovation.

Oxazolidinone derivative and preparation method and application thereof

A technology for drugs and compounds, applied in the field of blood coagulation, can solve the problems such as difficulty in purifying rivaroxaban, and achieve the effects of low price, easy purification and easy preparation

Active Publication Date: 2014-04-16
天津药业集团有限公司
View PDF7 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0010] Wherein, the yield of the first step reaction (preparation of 4-(4-morpholin-3-one) nitrobenzene) is only 17.6%, and rivaroxaban is difficult to purify

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Oxazolidinone derivative and preparation method and application thereof
  • Oxazolidinone derivative and preparation method and application thereof
  • Oxazolidinone derivative and preparation method and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0046] (S)-5-chloro-N-((2-oxo-3-(4-(2-oxo-2H-pyridin-1-yl)phenyl)-1,3-oxazolidine-5- Base) methyl) thiophene-2-carboxamide (I-1)

[0047]

[0048] Synthesis of A, 1-(4-aminophenyl)-1H-pyridin-2-one (compound VII)

[0049] Add 104g pyridin-2(1H)-one (compound IX), 200g p-iodoaniline (compound VIII), 26gCuI, 151g potassium carbonate, 18g8-hydroxyquinoline, 500mlDMF, nitrogen protection, heating and reflux, insulated and stirring reaction in the reaction flask 10h. Filtrate while hot, take the filtrate, evaporate the solvent under reduced pressure, add 1L of ethyl acetate to the residue, keep stirring at 0°C for 1 hour, filter, dry the solid, and refine it with 2L of acetonitrile to obtain 98g of a dark red solid. The refined mother liquor was concentrated to 500ml, stirred in an ice bath for 1h, and filtered to obtain 19g of a dark red solid. A total of 117g of the product was obtained, with a yield of 68.9%.

[0050] 1 H-NMR (DMSO-d 6 ), δ (ppm): 5.306 (s, 2H), 6.236 (...

Embodiment 2

[0074] (S)-5-bromo-N-((2-oxo-3-(4-(2-oxo-2H-pyridin-1-yl)phenyl)-1,3-oxazolidine-5- Base) methyl) thiophene-2-carboxamide (I-2)

[0075]

[0076] Melting point: 200.8~201.8℃;

[0077] 1 H-NMR (DMSO-d 6 ), δ(ppm): 3.580(t, 2H), 3.902(m, 1H), 4.221(t, 1H), 4.849(m, 1H), 6.308(t, 1H), 6.468(d, 1H), 7.193 (d, 1H), 7.426(m, 2H), 7.500(m, 1H), 7.637(m, 4H), 8.967(t, 1H);

[0078] MS(ESI): m / z=474(M+H);

[0079] HPLC: rt(%)=13.44(99.55);

[0080] [α] 20 D = -32.9° (c 0.3010, DMSO);

Embodiment 3

[0082] (S)-5-methyl-N-((2-oxo-3-(4-(2-oxo-2H-pyridin-1-yl)phenyl)-1,3-oxazolidine-5 -yl)methyl)thiophene-2-carboxamide (I-3)

[0083]

[0084] 1 H-NMR (DMSO-d 6 ), δ(ppm): 3.457(s, 3H), 3.600(t, 2H), 3.897(m, 1H), 4.224(t, 1H), 4.860(m, 1H), 6.314(t, 1H), 6.468 (d, 1H), 6.842 (d, 1H), 7.419 (d, 2H), 7.499 (m, 1H), 7.622 (m, 4H), 8.724 (t, 1H).

[0085] MS(ESI): m / z=410(M+H);

[0086] In the HPLC data that provides in the above-mentioned embodiment, the unit of retention time rt is minute, and HPLC parameter is:

[0087]Instrument: Waters 996-717-600 liquid chromatograph; Column: GL Science C18 column; Column temperature: 45°C; Eluent: phase A is potassium dihydrogen phosphate solution, phase B is potassium dihydrogen phosphate solution-acetonitrile ( 20:80); detection wavelength: 233nm; flow rate: 1.2ml / ml; gradient: 0.0min 55%A→5min 55%A→10min 40%A→20min 0%A→35min 0%A→36min 55%A.

[0088] In order to more fully illustrate the practice of the present invention, the fo...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to the field of blood coagulation, in particular to a novel oxazolidinone chiral compound with the structure of a general formula (1), a preparation method of the oxazolidinone chiral compound and a medicine combination containing the oxazolidinone chiral compound as well as an application of the oxazolidinone chiral compound serving as a bioactive substance to the prevention and / or treatment of diseases, wherein the definition of R is stated in the specification.

Description

technical field [0001] The present invention relates to the field of blood coagulation, in particular the present invention relates to novel oxazolidinone derivatives, their preparation methods and their use as bioactive substances in medicines. Background technique [0002] In the cardiovascular system of a living body, the process of coagulation of blood or the formation of certain solid masses in the blood is called thrombus formation, and the formed solid masses are called thrombus. Thrombosis is the abnormal coagulation of blood in a flowing state due to the activation of platelets and activation of coagulation factors. [0003] Blood coagulation is originally a protective mechanism of organisms, and there are mutually antagonistic coagulation system and anticoagulation system in blood. Under physiological conditions, coagulation factors in the blood are continuously activated to produce thrombin, forming a small amount of fibrin, which settles on the intima of the blo...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07D413/14A61K31/4439A61P7/02
Inventor 黄长江袁静张士俊商倩刘鹏付晓丽蔡志强龚珉汤立达徐为人
Owner 天津药业集团有限公司